antileukemic

Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.

将白细胞与化疗物微孔液体培养，MTT法检测细胞毒性。

Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.

MRD作为抗白物疗效标志,被于评患者危险,在某些例于调整治疗强度。